Day 1: Tuesday, March 17th, 2026 - EST/EDT (Eastern Daylight, GMT-4)
- Allie Spica - Portfolio Director, Access and Channel, Informa Connect
- Callie Mertel - Portfolio Manager, Access and Channel, Informa Connect
Join Jimmy Choi, Parkinson’s advocate, American Ninja Warrior and global inspiration, as he shares his extraordinary journey of resilience and advocacy. Diagnosed with Young Onset Parkinson’s at 27, Jimmy has defied expectations, completing marathons, breaking records and inspiring millions worldwide. In this keynote, explore the critical themes of patient affordability and access, offering a unique perspective on the challenges faced by patients navigating rare diseases and chronic conditions. Through his personal story, Jimmy highlights the importance of empowering patients, fostering community support and driving innovation in patient support programs.
Embrace possibility in the face of life-altering diagnoses
Champion access, affordability and systemic change
Build solutions through partnerships in healthcare
Redefine what’s possible for patients and caregivers
- Jimmy Choi - Endurance Athlete, 3-time World Record Holder, Parkinson’s Advocate
What are patients with chronic conditions experiencing when it comes to affordability and access? This session shares new national-level research capturing the perspectives of thousands of individuals with chronic illnesses. Explore the latest insights into how financial pressures and healthcare policy reforms are shaping the future of patient access and affordability.
- Kevin L. Hagan - President and CEO, PAN Foundation
- Amy Niles - Chief Mission Officer, PAN Foundation
In this exclusive roundtable, industry leaders will dive deep into how patient access needs are being assessed and the critical role affordability plays in shaping healthcare decisions. With a focus on real-world strategies and emerging trends, explore how data-driven insights are informing policy, operational changes, and innovative approaches to patient support.
- Geoff Fisher - Senior Director, Patient Access Programs Foundation, Patient Assistance Programs, GSK
- Wael Alkhalil - Head of Patient Access, Brand Strategy & Operations - Plasma Derived Therapies, Takeda
Understand how federal policy changes—both legislative and regulatory—will continue to shape the healthcare landscape, focusing on the One Big Beautiful Bill Act, Inflation Reduction Act, Most Favored Nation, PBM reform, and more
Gain insight into how these policy changes will affect patient access and your patient support programs
Review a roadmap for how your patient support program should plan for these major changes and incorporate these trends in your strategic planning
Join senior leaders for a candid discussion on industry challenges, from budget constraints to organizational changes. This session addresses how to make strategic decisions in an evolving healthcare landscape.
Respond to industry consolidation and its impact on patient services programs
Adapt to changing employee skill requirements as digital transformation reshapes patient support
Develop strategies for resource optimization to remain innovative in a neutral, stagnant market
Strategize on the increased complexity in the PA process
- Chris Dowd - Senior Vice President, ConnectiveRx
- Rhonda Hughes - Head of Patient Services, Biogen
- Todd Hudson - Vice President, Access, Trade & Patient Services, Pharvaris
- Joanne de Vries - Vice President & Head of Patient Services, Rare Blood Disorders & Oncology, Sanofi
This forward-thinking session examines artificial intelligence not merely as a technological trend but as a strategic tool that can transform patient support programs when implemented with purpose and vision. Join industry leaders as they share insights on moving beyond the AI hype cycle to create genuine value for patients and brands alike.
Evaluate AI through a patient-centric lens that balances operational efficiency with enhanced patient experience and outcomes
Develop a framework for AI implementation decisions based on therapeutic area needs, patient journey pain points and program objectives
Identify opportunities for AI to augment human touchpoints rather than replace them in critical patient interactions
Establish meaningful metrics for measuring AI's impact on prior authorization success, adherence and patient satisfaction
Examine different models for structuring field access teams to support reimbursement and access. Learn how to deploy field teams effectively based on therapeutic area needs and market dynamics.
Compare field team models from full-service field reimbursement managers to specialized roles
Identify the optimal deployment method for your specific product and market needs
Establish meaningful KPIs to measure field team effectiveness and value
Balance proactive and reactive engagement strategies for maximum field impact
This session examines innovative approaches to direct-to-consumer engagement that are reshaping how pharmaceutical companies connect with patients. Discover how manufacturers are developing new access models that respond to evolving consumer expectations while navigating regulatory requirements.
Analyze emerging direct-to-consumer frameworks that streamline the patient journey, potentially reducing intermediary touchpoints while improving medication access and adherence
Discover strategies for clearly communicating complex patient support programs directly to consumers, increasing program utilization and improving treatment outcomes
Learn techniques for maintaining regulatory compliance in direct patient communications while still delivering personalized, relevant information that drives engagement
Explore methods for seamlessly integrating access and support messaging into broader consumer marketing initiatives, creating a cohesive patient experience from awareness through ongoing therapy
- Jordan Armstrong - Vice Preisdent, Business Development, AssistRx
